Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology · Rheumatic Heart Disease

Surgical and Procedural Options

At a Glance

Significant rheumatic heart valve disease may need more than medicines. Treatment can include balloon opening of a narrowed mitral valve, surgical repair, or valve replacement; the choice depends on valve anatomy, surgical risk, age, blood-thinner needs, and pregnancy plans.

Because rheumatic heart disease creates a structural, mechanical problem—valves that are too narrow (stenosis) or too leaky (regurgitation)—medications alone are often not enough. To prevent irreversible damage to the heart muscle, many patients with significant, high-risk, or symptomatic valve disease will require interventions that physically open or replace the damaged valves [1][2].

Importantly, your care team does not simply wait until “medications fail.” They may recommend intervention even if diuretics are temporarily relieving your congestion, or if you are asymptomatic but show high-risk signs on an echo like pulmonary hypertension or a declining ejection fraction. Deciding on the right fix is a shared decision between you and a multidisciplinary heart team, which includes cardiologists, surgeons, and imaging specialists [3][4].

The First Option: Balloon Valvuloplasty (PMC)

If your main issue is a narrowed mitral valve, the preferred first treatment is often Percutaneous Mitral Commissurotomy (PMC) [1].

  • How it works: A thin tube (catheter) is threaded through a vein up to the heart. A balloon is inflated inside the narrowed mitral valve to stretch it open and break apart the fused “seams” [1][5].
  • Who is a candidate?: This is favorable if your valve is still flexible and not heavily calcified. You must also have no blood clots in the left atrium, and no severe valve leakage, as the balloon could make leaking worse [6][7].

Surgical Options: Repair vs. Replacement

If the valve is heavily calcified, severely leaking, or if multiple valves are involved, surgery is considered [6].

  • Valve Repair: Surgeons can sometimes reconstruct your own valve. While this avoids an artificial valve, rheumatic tissue is severely scarred, meaning repairs have a higher risk of failing over time [8][9].
  • Valve Replacement: The surgeon removes the damaged valve and replaces it with an artificial one [6].

Choosing Your Replacement Valve

Choosing between a mechanical and a tissue valve is a complex, individualized decision based on your age, ability to monitor blood thinners, and pregnancy plans. Neither choice is universally “best.”

Feature Mechanical Valve Bioprosthetic (Tissue) Valve
Material Durable carbon/metal [10] Animal tissue (cow or pig) [10]
Durability Likely to last a lifetime [10] Degrades over time (often much faster in younger patients), leading to re-operation [10]
Anticoagulation Requires lifelong warfarin, which carries bleeding risks [11] May only need short-term warfarin after surgery (unless you have atrial fibrillation, which requires it long-term) [12]
Pregnancy Risk Creates highly complex bleeding and clotting risks during pregnancy [10] Safer for pregnancy, but pregnancy accelerates the valve’s deterioration [12][13]

Managing Multiple Valves

Rheumatic heart disease often affects more than one valve [14][15]. If both the mitral and aortic valves are severely damaged, surgeons typically address both during the same operation [16]. If your tricuspid valve is leaking due to pressure buildup, the surgeon may perform a “tricuspid annuloplasty” (adding a ring to tighten it) during the procedure [16][17].

Transcatheter Options (TAVR/TMVR)

You may have heard of “keyhole” procedures like TAVR (Transcatheter Aortic Valve Replacement) or TMVR (Mitral). While common for age-related valve wear, these are highly investigational and heavily restricted for rheumatic disease because of the unique way rheumatic valves scar and fuse [18][19]. They are generally reserved only for highly selected patients at specialized centers who face prohibitive risks for open surgery [20][21].

🏥 What to Expect: Risks and Recovery

  • Balloon Procedures (PMC): Generally have a shorter recovery (days to weeks), but carry risks of creating severe valve leakage that requires emergency surgery, or dislodging a hidden clot.
  • Open-Heart Surgery: Requires a hospital stay of a week or more, with weeks to months of cardiac rehabilitation. Risks include infection, bleeding, and arrhythmias.
  • Life After a Valve: Having an artificial valve means you are at lifelong risk for valve infections (endocarditis) and blood clots on the valve. You must take antibiotics before dental procedures and strictly follow your team’s follow-up schedule.

Common questions in this guide

When might I need a procedure for rheumatic heart disease?
An intervention may be recommended when rheumatic valve narrowing or leakage is significant, causes symptoms, or produces high-risk findings such as pulmonary hypertension or a falling ejection fraction. Treatment may be advised even when diuretics temporarily relieve congestion. A multidisciplinary heart team considers your valve anatomy, other valves, surgical risk, and preferences.
How do I know if balloon mitral valvuloplasty is right for me?
A balloon mitral valvuloplasty, also called percutaneous mitral commissurotomy, is often considered for a narrowed mitral valve that remains flexible and is not heavily calcified. It is generally not suitable if there is a clot in the left atrium or severe mitral leakage, because the balloon may worsen the leak. Heart imaging helps your team assess whether the valve’s structure is suitable.
What is the difference between a mechanical and tissue heart valve?
Mechanical valves are made from durable carbon or metal and are likely to last a lifetime, but they require lifelong warfarin and regular blood monitoring. Tissue valves usually require less long-term anticoagulation, but they wear out over time, especially in younger patients. Pregnancy plans, age, bleeding risk, and the ability to attend monitoring visits all affect the choice, and pregnancy can speed tissue-valve deterioration.
If rheumatic disease affects several valves, can they be treated together?
If rheumatic disease has severely damaged more than one valve, surgeons may treat the mitral and aortic valves during the same operation. If the tricuspid valve leaks because of pressure buildup, a tricuspid annuloplasty may be added to tighten it. The final plan depends on the severity and anatomy of each valve.
Are TAVR and TMVR options for rheumatic valve disease?
TAVR, or transcatheter aortic valve replacement, and TMVR, or transcatheter mitral valve replacement, are not routine choices for rheumatic valve disease. Because rheumatic valves can be scarred and fused in unusual ways, these catheter-based procedures are generally reserved for highly selected patients at specialized centers who face prohibitive risk from open surgery.
What is recovery like after a rheumatic valve procedure?
Recovery after balloon treatment is often measured in days to weeks, while open-heart valve surgery may require a hospital stay of a week or more and cardiac rehabilitation for weeks to months. An artificial valve requires lifelong follow-up, attention to infection prevention, and the prescribed plan for blood-thinner treatment. People with artificial valves should follow their heart team’s instructions about antibiotics before dental procedures and monitoring for blood clots.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my mitral valve anatomy—specifically the 'Wilkins score' or the amount of calcium—make me a good candidate for the balloon procedure (PMC)?
  2. 2.Given my age, bleeding risk, and lifestyle, what are the individualized trade-offs for me between a mechanical valve and a bioprosthetic one?
  3. 3.If I choose a mechanical valve, what support does your clinic offer to help me manage my warfarin levels and INR testing?
  4. 4.How does the condition of my aortic and tricuspid valves affect the timing or type of surgery you are recommending?
  5. 5.Are there signs of high pulmonary pressure or chamber enlargement that suggest we should intervene now, rather than waiting?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    A study of Clinical Profile and in Hospital Outcomes of patients undergoing Percutaneous Transvenous Mitral Commissurotomy at a Tertiary Care Center of Nepal.

    Yadav S, Shah S, Gajurel RM, et al.

    Annals of medicine and surgery (2012) 2022; (84()):104867 doi:10.1016/j.amsu.2022.104867.

    PMID: 36536708
  2. 2

    Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association.

    Kumar RK, Antunes MJ, Beaton A, et al.

    Circulation 2020; (142(20)):e337-e357 doi:10.1161/CIR.0000000000000921.

    PMID: 33073615
  3. 3

    Society of cardiothoracic surgery in great Britain and Ireland guidance for adult mitral valve disease and interventions.

    Vohra HA, Burton S, Yadav R, et al.

    BMJ surgery, interventions, & health technologies 2025; (7(1)):e000328 doi:10.1136/bmjsit-2024-000328.

    PMID: 40735743
  4. 4

    Severe Mitral Annular Calcification: Multimodality Imaging for Therapeutic Strategies and Interventions.

    Eleid MF, Foley TA, Said SM, et al.

    JACC. Cardiovascular imaging 2016; (9(11)):1318-1337 doi:10.1016/j.jcmg.2016.09.001.

    PMID: 27832900
  5. 5

    Update on percutaneous mitral commissurotomy.

    Nunes MC, Nascimento BR, Lodi-Junqueira L, et al.

    Heart (British Cardiac Society) 2016; (102(7)):500-7 doi:10.1136/heartjnl-2015-308091.

    PMID: 26743926
  6. 6

    Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.

    Wunderlich NC, Dalvi B, Ho SY, et al.

    Current cardiology reports 2019; (21(3)):14 doi:10.1007/s11886-019-1099-7.

    PMID: 30815750
  7. 7

    Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.

    Mohamed Ali A, Packer EJS, Omdal TR, et al.

    Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.

    PMID: 37544629
  8. 8

    Mitral valve repair versus replacement in patients with rheumatic heart disease.

    Chen SW, Chen CY, Chien-Chia Wu V, et al.

    The Journal of thoracic and cardiovascular surgery 2022; (164(1)):57-67.e11 doi:10.1016/j.jtcvs.2020.07.117.

    PMID: 32994098
  9. 9

    Features of rheumatic mitral valves and a grading system to identify suitable repair cases in China.

    Luo T, Han J, Meng X

    Journal of thoracic disease 2017; (9(9)):3138-3147 doi:10.21037/jtd.2017.08.121.

    PMID: 29221289
  10. 10

    Bioprosthetic versus mechanical mitral valve replacements in patients with rheumatic heart disease.

    Chen CY, Chan YH, Wu VC, et al.

    The Journal of thoracic and cardiovascular surgery 2023; (165(3)):1050-1060.e8 doi:10.1016/j.jtcvs.2021.03.033.

    PMID: 33840468
  11. 11

    Surgical implications of rheumatic heart disease in Indian females.

    Chandra A, Gutti R, Sisodia A, et al.

    Indian journal of thoracic and cardiovascular surgery 2026; (42(1)):59-77 doi:10.1007/s12055-025-02068-6.

    PMID: 41438533
  12. 12

    Effects of mitral valve disease etiology on the outcomes of mechanical and biological valve replacement: retrospective cohort study.

    Chen CY, Chang FC, Lin CP, et al.

    International journal of surgery (London, England) 2024; (110(6)):3495-3503 doi:10.1097/JS9.0000000000001283.

    PMID: 38498356
  13. 13

    Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC).

    van Hagen IM, Roos-Hesselink JW, Ruys TP, et al.

    Circulation 2015; (132(2)):132-42 doi:10.1161/CIRCULATIONAHA.115.015242.

    PMID: 26100109
  14. 14

    Patterns of Rheumatic Heart Disease and Treatment Practices at Tertiary Care Center in Nepal: A Descriptive Cross-sectional Study.

    Nepal R, Bista M, Dhungana SP

    JNMA; journal of the Nepal Medical Association 2020; (58(230)):784-788 doi:10.31729/jnma.5405.

    PMID: 34504361
  15. 15

    Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

    Antunes MJ, Rodríguez-Palomares J, Prendergast B, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2017; (52(6)):1022-1030 doi:10.1093/ejcts/ezx279.

    PMID: 28950325
  16. 16

    Long-Term Outcomes After Mitral Valve Replacement and Tricuspid Annuloplasty in Rheumatic Patients.

    Itzhaki Ben Zadok O, Sagie A, Vaturi M, et al.

    The Annals of thoracic surgery 2019; (107(2)):539-545 doi:10.1016/j.athoracsur.2018.09.012.

    PMID: 30617023
  17. 17

    Impact of concomitant tricuspid annuloplasty on right ventricular remodeling in patients with rheumatic mitral valve disease.

    Zhong Y, Bai W, Wang H, et al.

    Cardiovascular ultrasound 2021; (19(1)):16 doi:10.1186/s12947-021-00245-2.

    PMID: 33663519
  18. 18

    Transcatheter Aortic Valve Replacement in Rheumatic Aortic Stenosis: A Comprehensive Review.

    Okor I, Bob-Manuel T, Garikapati K, et al.

    Current problems in cardiology 2021; (46(12)):100843 doi:10.1016/j.cpcardiol.2021.100843.

    PMID: 33994024
  19. 19

    Transcatheter aortic valve replacement in patients with degenerative calcified rheumatic aortic stenosis: A 10-patient case series.

    Saji M, Highchi R, Iguchi N, et al.

    International journal of cardiology 2019; (280()):38-42 doi:10.1016/j.ijcard.2018.11.090.

    PMID: 30503242
  20. 20

    State of the Art: Transcatheter Edge-to-Edge Repair for Complex Mitral Regurgitation.

    Flint N, Price MJ, Little SH, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2021; (34(10)):1025-1037 doi:10.1016/j.echo.2021.03.240.

    PMID: 33872701
  21. 21

    CT for Pre- and Postprocedural Evaluation of Transcatheter Mitral Valve Replacement.

    Ranganath P, Moore A, Guerrero M, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2020; (40(6)):1528-1553 doi:10.1148/rg.2020200027.

    PMID: 33001784

This page explains surgical and catheter-based options for rheumatic heart valve disease for informational purposes only and does not constitute medical advice. Your multidisciplinary heart team should determine whether a procedure, valve type, or timing is right for you.

Get notified when new evidence is published on rheumatic congestive heart failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.